Related Experiment Video
Updated: Jun 12, 2026

Embolic Middle Cerebral Artery Occlusion (MCAO) for Ischemic Stroke with Homologous Blood Clots in Rats
Published on: September 17, 2014
Cerebral embolism following thrombolytic therapy for acute myocardial infarction: the second reported case
1Department of Cardiology, Rize University Medical School, Rize, Turkey. drmehmetbostan@hotmail.com
Insights
Thrombolytic therapy for ST-elevation myocardial infarction can cause rare complications like stroke. Arterial fibrillation was a key factor in this reported cerebrovascular accident case.
Area of Science:
- Cardiology
- Neurology
Background:
- ST-elevation myocardial infarction (STEMI) is a critical condition requiring prompt restoration of coronary blood flow.
- Primary percutaneous coronary intervention (PCI) is preferred over thrombolytic therapy (TT) for STEMI, but TT remains a viable option.
- While TT reduces STEMI mortality, it carries risks of serious side effects, including bleeding and hypotension.
Observation:
- This report details an extremely rare case of cerebrovascular accident (CVA) secondary to cerebral emboli after thrombolytic therapy for STEMI.
- The patient had a history of arterial fibrillation (AF), a significant predisposing factor for embolic events.
Findings:
- Cerebral emboli leading to CVA is a rare complication of thrombolytic therapy in STEMI patients.
- Arterial fibrillation significantly increases the risk of embolic stroke in patients undergoing thrombolytic therapy.
Implications:
- This case highlights the importance of considering embolic risk, particularly in patients with AF, when administering thrombolytic therapy for STEMI.
- Further investigation into the specific mechanisms and risk stratification for embolic complications following TT in STEMI patients is warranted.
Abstract:
ST-elevation myocardial infarction (STEMI), caused by acute occlusion of the infarct-related coronary artery, is an emergency condition. The primary therapy is restoration of full antegrade flow by either percutaneus coronary intervention (PCI) or thrombolytic therapy (TT). Although primary PCI is superior to TT in patients with STEMI, there are many limitations in clinical practice. TT decreases mortality in STEMI patients, but as experience with thrombolytic agents grows, the potential risks of serious side effects become more apparent. The major complications are bleeding, hypotension and skin rash. We report on a case of cerebrovascular accident (CVA) caused by cerebral emboli following TT. We concluded that the fact that the patient was in arterial fibrillation (AF) was a major contributing factor to her CVA. This is an extremely rare condition, and our case appears to be the second one reported on in the literature.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

